8-K
Current Report
Prelude Therapeutics Inc Filed Acc 0001193125-25-241968
Executive or director change · Regulation FD disclosure
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading prld-20251015.htm…